Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologists.

Gary TozbikianMarilyn M BuiDavid G HicksShabnam JafferThaer KhouryHannah Y WenSavitri KrishnamurthyShi Wei

Published in: Histopathology (2024)

Awareness of BC cases that are negative for HER protein overexpression/gene amplification and the related clinical relevance for targeted therapy highlight the importance of accurate HER2 IHC scoring for optimal treatment selection.

Keyphrases

poor prognosis
healthcare
primary care
binding protein
cell proliferation
genome wide
high resolution
copy number
clinical practice
nucleic acid
protein protein
dna methylation
long non coding rna
mass spectrometry
small molecule
label free